The World Health Organization (WHO) has reported progress in global efforts to combat antimicrobial resistance (AMR), with more countries adopting national action plans. However, implementation and funding gaps continue to put the world off track to achieve key targets set for 2030.
According to the 2026 annual survey, 173 of the 183 countries assessed have developed national action plans to address AMR, compared with 79 countries in 2017. However, only 42 countries reported that their plans were both funded and implemented.
The survey was jointly conducted by the WHO, United Nations Environment Programme (UNEP), World Organisation for Animal Health (WOAH) and Food and Agriculture Organization (FAO).
AMR occurs when bacteria and other microorganisms develop the ability to resist medicines designed to treat infections. The WHO has warned that the growing resistance, often linked to the misuse and overuse of antimicrobial medicines, threatens the effectiveness of modern medical treatments.
At the 2024 United Nations General Assembly, countries agreed on several targets to address AMR by 2030. However, the WHO said current progress remains insufficient. One in six laboratory-confirmed bacterial infections is already resistant to antibiotics, while drug-resistant infections could contribute to more than 39 million deaths globally over the next 25 years if current trends continue.
Infection prevention programmes remain limited
The survey identified significant gaps in the implementation of infection prevention and control (IPC) measures. Although 128 countries have national IPC programmes and guidelines, up from 90 in 2018, only 69 countries (38%) have implemented them nationwide.
This remains considerably below the 2030 target of 90% nationwide implementation.
Gaps in laboratory testing capacity
The report found that 131 countries have national reference laboratories capable of testing antibiotic resistance in common bacteria. However, only 66 countries reported having the capacity to test for both bacterial and fungal resistance.
Under the 2030 commitments, countries aim to ensure that 80% have the required laboratory testing capabilities.
To support these efforts, the WHO has released two toolkits to strengthen diagnostic capacity, covering essential tests and laboratory procedures.
Surveillance systems expand, but data integration remains weak
Global monitoring of antimicrobial use and resistance has improved since 2017. The number of countries monitoring antibiotic consumption has increased from 65 to 113, while those tracking antimicrobial resistance have risen from 39 to 109.
However, only 21 countries reported integrating data on antibiotic use and resistance. The WHO highlighted that combining these datasets is essential to understand the relationship between antimicrobial consumption and rising resistance and to develop effective national strategies.
The findings indicate that while global participation in AMR initiatives has increased, stronger funding, nationwide implementation, laboratory capacity and integrated surveillance systems are needed to achieve the 2030 targets.
